These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 29501417

  • 1. Establishment of reference values in a healthy population and interpretation of serum PTH concentrations in hemodialyzed patients according to the KDIGO Guidelines using the Lumipulse® G whole PTH (3rd generation) assay.
    Cavalier E, Salsé M, Dupuy AM, Bargnoux AS, Watar F, Souberbielle JC, Delanaye P, Cristol JP.
    Clin Biochem; 2018 Apr; 54():119-122. PubMed ID: 29501417
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values.
    Cavalier E, Delanaye P, Vranken L, Bekaert AC, Carlisi A, Chapelle JP, Souberbielle JC.
    Nephrol Dial Transplant; 2012 May; 27(5):1950-6. PubMed ID: 21940481
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients.
    Souberbielle JC, Massart C, Brailly-Tabard S, Cormier C, Cavalier E, Delanaye P, Chanson P.
    Eur J Endocrinol; 2016 Mar; 174(3):315-23. PubMed ID: 26628583
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory?
    Souberbielle JC, Cavalier E, Jean G.
    Clin Chem Lab Med; 2010 Jun; 48(6):769-74. PubMed ID: 20298134
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy.
    Bekő G, Butz H, Berta K, Tislér A, Olajos F, Vásárhelyi B, Patócs A.
    Clin Chem Lab Med; 2013 Jun; 51(6):1251-6. PubMed ID: 23241601
    [Abstract] [Full Text] [Related]

  • 11. Higher parathyroid hormone (PTH) concentrations with the Architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods.
    Monge M, Jean G, Bacri JL, Lemaitre V, Masy E, Joly D, Souberbielle JC.
    Clin Chem Lab Med; 2009 Jun; 47(3):362-6. PubMed ID: 19199835
    [Abstract] [Full Text] [Related]

  • 12. Analytical and clinical evaluation of the new Fujirebio Lumipulse®G non-competitive assay for 25(OH)-vitamin D and three immunoassays for 25(OH)D in healthy subjects, osteoporotic patients, third trimester pregnant women, healthy African subjects, hemodialyzed and intensive care patients.
    Cavalier E, Lukas P, Bekaert AC, Peeters S, Le Goff C, Yayo E, Delanaye P, Souberbielle JC.
    Clin Chem Lab Med; 2016 Aug 01; 54(8):1347-55. PubMed ID: 26741345
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid Hormone Concentrations in Maintenance Hemodialysis: Longitudinal Evaluation of Intact and Biointact Assays.
    Berner C, Marculescu R, Frommlet F, Kurnikowski A, Schairer B, Aigner C, Bieglmayer C, Hecking M.
    Kidney Med; 2021 Aug 01; 3(3):343-352.e1. PubMed ID: 34136780
    [Abstract] [Full Text] [Related]

  • 14. Moving from the second to the third generation Roche PTH assays: what are the consequences for clinical practice?
    Dupuy AM, Bargnoux AS, Morena M, Lauret E, Souberbielle JC, Cavalier E, Cristol JP.
    Clin Chem Lab Med; 2018 Dec 19; 57(2):244-249. PubMed ID: 30183664
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D, bone alkaline phosphatase and parathyroid hormone in healthy subjects and haemodialysed patients from West Africa: impact of reference ranges and parathyroid hormone generation assays on the KDIGO guidelines.
    Cavalier E, Sagou Yayo E, Attoungbre-Hauhouot ML, Konan JL, Yao-Yapo C, Monnet D, Gnionsahé A, Souberbielle JC, Delanaye P.
    Clin Kidney J; 2019 Apr 19; 12(2):288-293. PubMed ID: 30976410
    [Abstract] [Full Text] [Related]

  • 16. Practical considerations in PTH testing.
    Souberbielle JC, Friedlander G, Cormier C.
    Clin Chim Acta; 2006 Apr 19; 366(1-2):81-9. PubMed ID: 16310759
    [Abstract] [Full Text] [Related]

  • 17. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D, Franzson L, Hoffmann JP, Isaksson A, Kaufman JM, Leary E, Müller C, Nakatsuka K, Nishizawa Y, Reinauer H, Riesen W, Roth HJ, Steinmüller T, Troch T, Bergmann P.
    Clin Lab; 2002 Apr 19; 48(3-4):131-41. PubMed ID: 11934215
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the Elecsys PTH(1-84) assay with four contemporary second generation intact PTH assays and association with other biomarkers in chronic kidney disease patients.
    Tan K, Ong L, Sethi SK, Saw S.
    Clin Biochem; 2013 Jun 19; 46(9):781-6. PubMed ID: 23384535
    [Abstract] [Full Text] [Related]

  • 19. The third/second generation PTH assay ratio as a marker for parathyroid carcinoma: evaluation using an automated platform.
    Cavalier E, Betea D, Schleck ML, Gadisseur R, Vroonen L, Delanaye P, Daly AF, Beckers A.
    J Clin Endocrinol Metab; 2014 Mar 19; 99(3):E453-7. PubMed ID: 24423313
    [Abstract] [Full Text] [Related]

  • 20. Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays.
    Brossard JH, Lepage R, Cardinal H, Roy L, Rousseau L, Dorais C, D'Amour P.
    Clin Chem; 2000 May 19; 46(5):697-703. PubMed ID: 10794753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.